Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.
Simona ZaamiAlfredo OrricoFabrizio SignoreAnna Franca CavaliereMarta MazziEnrico MarinelliPublished in: Genes (2021)
New technologies such as non-invasive prenatal testing (NIPT), capable of analyzing cell-free fetal DNA in the maternal bloodstream, have become increasingly widespread and available, which has in turn led to ethical and policy challenges that need addressing. NIPT is not yet a diagnostic tool, but can still provide information about fetal genetic characteristics (including sex) very early in pregnancy, and there is no denying that it offers valuable opportunities for pregnant women, particularly those at high risk of having a child with severe genetic disorders or seeking an alternative to invasive prenatal testing. Nonetheless, the ethical, legal and social implications (ELSI) include multiple aspects of informed decision-making, which can entail risks for the individual right to procreative autonomy, in addition to the potential threats posed by sex-selective termination of pregnancy (in light of the information about fetal sex within the first trimester), and the stigmatization and discrimination of disabled individuals. After taking such daunting challenges into account and addressing NIPT-related medicolegal complexities, the review's authors highlight the need for an ethically and legally sustainable framework for the implementation of NIPT, which seems poised to become a diagnostic tool, as its scope is likely to broaden in the near future.
Keyphrases
- pregnant women
- cell free
- pregnancy outcomes
- decision making
- mental health
- healthcare
- circulating tumor
- genome wide
- public health
- preterm birth
- health information
- primary care
- human health
- copy number
- gram negative
- sensitive detection
- single molecule
- risk assessment
- birth weight
- physical activity
- dna methylation
- current status
- body mass index
- nucleic acid